Align Technology (ALGN) Stock
Key stats
- Market cap
- $12.13B
- Price / Earnings ratio
- 25.0x
- EPS (TTM)
- $6.88
- Volume
- Loading
- 52-week high
- $200.44
- 52-week low
- $130.23
- EPS vs analyst estimate
- +18.6%Q3 FY25 · $2.61 vs $2.20
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with ALGN
Recent news

Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
ALGN

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
ALGN

Align Technology Q3 Earnings Call Highlights
Align Technology Q3 Earnings Call Highlights
ALGN

Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics
ALGN
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 67.01
- MACD 12/26/9
- 5.71
- EMA 9 of MACD
- 3.32
- MACD histogram
- 2.40
- SMA 50
- $151.34
- Price above SMA 50
- EMA 50
- $156.05
- Price above EMA 50
- SMA 200
- $168.64
- Price above SMA 200
- EMA 200
- $162.85
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $2.27 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
ALGN

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
ALGN

Align Technology Q3 Earnings Call Highlights
Align Technology Q3 Earnings Call Highlights
ALGN

Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Align Technology (ALGN) Q3 Earnings: A Look at Key Metrics
ALGN

Align Technology (ALGN) Beats Q3 Earnings and Revenue Estimates
Align Technology (ALGN) Beats Q3 Earnings and Revenue Estimates
ALGN

Align Technology Announces Third Quarter 2026 Financial Results
Align Technology Announces Third Quarter 2026 Financial Results
ALGN

Align Technology Announces CEO Succession Plan
Align Technology Announces CEO Succession Plan
ALGN

Is the Options Market Predicting a Spike in Align Technology Stock?
Is the Options Market Predicting a Spike in Align Technology Stock?
ALGN

Align Technology Commits Additional $1 Million to the American Association of Orthodontists Foundation to Support the Next Generation of Orthodontic Educators and Leaders
Align Technology Commits Additional $1 Million to the American Association of Orthodontists Foundation to Support the Next Generation of Orthodontic Educators and Leaders
ALGN

Invisalign's Moment of Truth: Will International Growth Save ALGN on Oct 28?
Invisalign's Moment of Truth: Will International Growth Save ALGN on Oct 28?
ALGN
News tone: automated (AI) classification of the article's content, not a price prediction.
About Align Technology
Align Technology is a manufacturer of 3D digital scanners and clear aligners used in orthodontics. It is headquartered in San Jose, California; it manufactures the aligners in Juarez, Mexico and its scanners in Israel and China.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph M. Hogan | President, CEO & Director | 1957 |
| Mr. John F. Morici | CFO & Executive VP of Global Finance | 1967 |
| Mr. Zelko Relic | Executive VP & CTO | 1965 |
| Ms. Shirley Stacy | Vice President of Corporate Communications & Investor Relations | — |
| Richardson Jaime Holte | Executive Vice President of Global Human Resources | — |
| Ms. Sreelakshmi Kolli | Executive VP and Chief Product & Digital Officer | 1975 |
| Mr. Srini Kaza | Executive Vice President of Research & Development | — |
| Dr. Mitra Derakhshan | Executive VP, Chief Clinical Officer, Global Treatment Planning & Clinical Services | — |
| Mr. David Carr | Executive VP and MD of EMEA | — |
| Mr. Frank Quinn | Executive VP & MD of Americas Region | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 67.01
- MACD 12/26/9
- 5.71
- EMA 9 of MACD
- 3.32
- MACD histogram
- 2.40
- SMA 50
- $151.34
- Price above SMA 50
- EMA 50
- $156.05
- Price above EMA 50
- SMA 200
- $168.64
- Price above SMA 200
- EMA 200
- $162.85
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $155.00
- Average
- $183.86
- High
- $215.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -10.1 | +9.1 | ||||||||||
| 2022 | -23.6 | +0.6 | -13.0 | -35.1 | -10.1 | -10.7 | +13.6 | -13.8 | -15.7 | -9.9 | +1.9 | +4.5 |
| 2023 | +27.1 | +9.5 | +8.3 | -0.6 | -10.9 | +19.0 | +9.7 | -1.7 | -18.6 | -38.4 | +16.7 | +24.3 |
| 2024 | -0.6 | +10.6 | +9.3 | -11.7 | -9.6 | -5.1 | -2.8 | +3.9 | +12.3 | -16.4 | +11.6 | -10.9 |
| 2025 | +5.1 | -13.3 | -9.3 | +9.6 | +2.4 | +6.1 | -33.6 | +4.0 | -8.7 | +8.1 | +6.3 | +6.4 |
| 2026 | +4.5 | +16.2 | -9.3 | +1.9 | -2.2 | -0.7 | -6.8 | -7.6 | -6.2 | +3.1 | +11.6 |



